Note that some links may require subscriptions.
José Baselga, MD, has landed a new job after an ethics scandal drove him out of Memorial Sloan Kettering Cancer Center: head of AstraZeneca’s oncology R&D unit. (FierceBiotech)
Could the Chinese scientist who claimed to create gene-edited babies be executed? (Gizmodo)
Researchers are using chemical compositions mimicking bear bile to maintain a heartbeat. How else can ancient remedies inform modern medicine? (National Geographic)
The latest Johnson & Johnson trial begins in California, where the company faces allegations that its talc-based products such as baby powder may cause cancer. (Reuters)
New California Gov. Gavin Newsom (D) began his term by proposing to expand Medicaid coverage to include undocumented young adults. (CNN)
Amgen, maker of the PCSK9 inhibitor evolocumab (Repatha), lost another round in its patent-infringement suit targeting the rival drug alirocumab (Praluent) — this one at the Supreme Court — but the fight continues. (Reuters)
And speaking of the High Nine, Justice Ruth Bader Ginsburg missed arguments on Monday while she recovers from lung cancer surgery. (AP)
Also in Washington, health advocates lobby Congress to reclassify schizophrenia as a brain disease instead of a mental illness, which could distribute more money towards research and finding a cure. (Politico)
Amidst reconstruction after Hurricane Maria, Puerto Rico faces another rapidly expanding crisis: opioids. (AP)
Minneapolis cardiologist Elizabeth Klodas, MD, is on a mission to reduce statin use. (CNN)
NIH advises health researchers to tighten security measures: Chinese spies might be trying to steal their data. (New York Times)
What happens when a patient narrowly skirts death? A physician interviews thousands of survivors to get to the bottom of the life-changing experience, on KevinMD.
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: [email protected]